Genomic and Phenotypic Characterization of a Colistin-Resistant Escherichia coli Isolate Co-Harboring bla_NDM-5, bla_OXA-1, and bla_CTX-M-55 Isolated from Urine

References

• Jacobsen SM, Stickler DJ, Mobley HLT, Shirtliff ME. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev. 2008;21(1):26. doi:10.1128/cmr.00019-07
   PubMed Web of Science ®Google Scholar
• Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010;8(1):26–38. doi:10.1038/nrmicro2265
   PubMed Web of Science ®Google Scholar
• Toval F, Koehler C-D, Vogel U, et al. Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection. J Clin Microbiol. 2014;52(2):407–418. doi:10.1128/jcm.02069-13
   PubMed Web of Science ®Google Scholar
• Temkin E, Adler A, Lerner A, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management. Ann N Y Acad Sci. 2014;1323(1):22–42. doi:10.1111/nyas.12537
   Web of Science ®Google Scholar
• Petty NK, Ben Zakour NL, Stanton-Cook M, et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci USA. 2014;111(15):5694–5699. doi:10.1073/pnas.1322678111
   PubMed Web of Science ®Google Scholar
• Garcia-Fernandez A, Villa L, Bibbolino G, et al. Novel insights and features of the NDM-5-producing Escherichia coli sequence Type 167 high-risk clone. mSphere. 2020;5(2). doi:10.1128/mSphere.00269-20
   Web of Science ®Google Scholar
• Roer L, Overballe-Petersen S, Hansen F, et al. Escherichia coli sequence type 410 is causing new international high-risk clones. mSphere. 2018;3(4). doi:10.1128/mSphere.00337-18
   PubMed Web of Science ®Google Scholar
• Liu Z, Li J, Wang X, et al. Novel variant of New Delhi metallo-beta-lactamase, NDM-20, in Escherichia coli. Front Microbiol. 2018;9. doi:10.3389/fmicb.2018.00248
   Web of Science ®Google Scholar
• Bottery MJ, Wood AJ, Brockhurst MA. Adaptive modulation of antibiotic resistance through intragenomic coevolution. Nat Ecol Evol. 2017;1(9):1364–1369. doi:10.1038/s41559-017-0242-3
   Web of Science ®Google Scholar
• Jeannot K, Bolard A, Plésiat P. Resistance to polymyxins in Gram-negative organisms. Int J Antimicrob Agents. 2017;49(5):526–535. doi:10.1016/j.ijantimicag.2016.11.029
   PubMed Web of Science ®Google Scholar
• Telke AA, Olaitan AO, Morand S, Rolain JM. soxRS induces colistin hetero-resistance in Enterobacter asburiae and Enterobacter cloacae by regulating the acrAB-tolC efflux pump. J Antimicrob Chemother. 2017;72(10):2715–2721. doi:10.1093/jac/dkx215
   PubMed Web of Science ®Google Scholar
• Liao W, Lin J, Jia H, et al. Resistance and heteroresistance to colistin in Escherichia coli isolates from Wenzhou, China. Infect Drug Resist. 2020;13:3551–3561. doi:10.2147/idr.S273784
   Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.
   Google Scholar
• Green MR, Sambrook J. Isolating DNA from gram-negative bacteria. Cold Spring Harb Protoc. 2017;2017(1). doi:10.1101/pdb.prot093369
   Google Scholar
• Schumacher A, Steinke P, Bohnert JA, Akova M, Jonas D, Kern WV. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli. J Antimicrob Chemother. 2006;57(2):344–348. doi:10.1093/jac/dki446
   PubMed Web of Science ®Google Scholar
• Baron SA, Rolain JM. Efflux pump inhibitor CCCP to rescue colistin susceptibility in mcr-1 plasmid-mediated colistin-resistant strains and Gram-negative bacteria. J Antimicrob Chemother. 2018;73(7):1862–1871. doi:10.1093/jac/dky134
   PubMed Web of Science ®Google Scholar
• Kim M, Park J, Park W. Genomic and phenotypic analyses of multidrug-resistant Acinetobacter baumannii NCCP 16007 isolated from a patient with a urinary tract infection. Virulence. 2021;12(1):150–164. doi:10.1080/21505594.2020.1867421
   PubMed Web of Science ®Google Scholar
• Zhao X, Lv Y, Adam FEA, et al. Comparison of antimicrobial resistance, virulence genes, phylogroups, and biofilm formation of Escherichia coli isolated from intensive farming and free-range sheep. Front Microbiol. 2021;12:699927. doi:10.3389/fmicb.2021.699927
   Web of Science ®Google Scholar
• Ma T, Fu J, Xie N, et al. Fitness cost of bla(NDM-5)-carrying p3R-IncX3 plasmids in wild-type NDM-free Enterobacteriaceae. Microorganisms. 2020;8(3):377. doi:10.3390/microorganisms8030377
   Web of Science ®Google Scholar
• Lane MC, Simms AN, Mobley HLT. Complex interplay between type 1 fimbrial expression and flagellum-mediated motility of uropathogenic Escherichia coli. J Bacteriol. 2007;189(15):5523–5533. doi:10.1128/jb.00434-07
   Web of Science ®Google Scholar
• Lee I, Ouk Kim Y, Park SC, Chun J. OrthoANI: an improved algorithm and software for calculating average nucleotide identity. Int J Syst Evol Microbiol. 2016;66(2):1100–1103. doi:10.1099/ijsem.0.000760
   PubMed Web of Science ®Google Scholar
• Long HY, Feng Y, Ma K, Liu L, McNally A, Zong ZY. The co-transfer of plasmid-borne colistin-resistant genes mcr-1 and mcr-3.5, the carbapenemase gene bla(NDM-5) and the 16S methylase gene rmtB from Escherichia coli. Sci Rep. 2019;9(1):6. doi:10.1038/s41598-018-37125-1
   Web of Science ®Google Scholar
• Brilhante M, Menezes J, Belas A, et al. OXA-181-producing extraintestinal pathogenic Escherichia coli sequence type 410 isolated from a dog in Portugal. Antimicrob Agents Chemother. 2020;64(4):6. doi:10.1128/aac.02298-19
   Web of Science ®Google Scholar
• Overballe-Petersen S, Roer L, Ng K, et al. Complete nucleotide sequence of an Escherichia coli sequence Type 410 strain carrying bla(NDM-5) on an IncF multidrug resistance plasmid and bla(OXA-181) on an IncX3 plasmid. Genome Announc. 2018;6(5). doi:10.1128/genomeA.01542-17
   Google Scholar
• Hsiao W, Wan I, Jones SJ, Brinkman FS. IslandPath: aiding detection of genomic islands in prokaryotes. Bioinformatics. 2003;19(3):418–420. doi:10.1093/bioinformatics/btg004
   PubMed Web of Science ®Google Scholar
• Schaufler K, Semmler T, Wieler LH, et al. Clonal spread and interspecies transmission of clinically relevant ESBL-producing Escherichia coli of ST410-another successful pandemic clone? FEMS Microbiol Ecol. 2016;92(1):9. doi:10.1093/femsec/fiv155
   Web of Science ®Google Scholar
• Richter M, Rossello-Mora R. Shifting the genomic gold standard for the prokaryotic species definition. Proc Natl Acad Sci U S A. 2009;106(45):19126–19131. doi:10.1073/pnas.0906412106
   PubMed Web of Science ®Google Scholar
• Jain C, Rodriguez-R LM, Phillippy AM, Konstantinidis KT, Aluru S. High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundaries. Nat Commun. 2018;9(1):8. doi:10.1038/s41467-018-07641-9
   Web of Science ®Google Scholar
• Martinez JL, Rojo F. Metabolic regulation of antibiotic resistance. FEMS Microbiol Rev. 2011;35(5):768–789. doi:10.1111/j.1574-6976.2011.00282.x
   PubMed Web of Science ®Google Scholar
• Gullberg E, Cao S, Berg OG, et al. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 2011;7(7):e1002158. doi:10.1371/journal.ppat.1002158
   PubMed Web of Science ®Google Scholar
• Durão P, Balbontín R, Gordo I. Evolutionary mechanisms shaping the maintenance of antibiotic resistance. Trends Microbiol. 2018;26(8):677–691. doi:10.1016/j.tim.2018.01.005
   PubMed Web of Science ®Google Scholar
• Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2(2):123–140. doi:10.1038/nrmicro818
   PubMed Web of Science ®Google Scholar
• Soto SM, Smithson A, Horcajada JP, Martinez JA, Mensa JP, Vila J. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin Microbiol Infect. 2006;12(10):1034–1036. doi:10.1111/j.1469-0691.2006.01543.x
   PubMed Web of Science ®Google Scholar
• Horesh G, Blackwell GA, Tonkin-Hill G, Corander J, Heinz E, Thomson NR. A comprehensive and high-quality collection of Escherichia coli genomes and their genes. Microb Genom. 2021;7(2). doi:10.1099/mgen.0.000499
   Web of Science ®Google Scholar
• San Millan A, MacLean RC. Fitness costs of plasmids: a limit to plasmid transmission. Microbiol Spectr. 2017;5(5). doi:10.1128/microbiolspec.MTBP-0016-2017
   PubMed Web of Science ®Google Scholar
• Ho PL, Wang Y, Liu MCJ, et al. IncX3 epidemic plasmid carrying bla(NDM-5) in Escherichia coli from Swine in multiple geographic areas in China. Antimicrob Agents Chemother. 2018;62(3):5. doi:10.1128/aac.02295-17
   Web of Science ®Google Scholar
• Li X, Fu Y, Shen M, et al. Dissemination of bla(NDM-5) gene via an IncX3-type plasmid among non-clonal Escherichia coli in China. Antimicrob Resist Infect Control. 2018;7(1):59. doi:10.1186/s13756-018-0349-6
   Web of Science ®Google Scholar
• Andersson DI, Hughes D. Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol. 2014;12(7):465–478. doi:10.1038/nrmicro3270
   PubMed Web of Science ®Google Scholar
• Huang J, Ma S, Yu Q, et al. Whole genome sequence of an Escherichia coli ST410 isolate co-harbouring bla(NDM-5), bla(OXA-1), bla(CTX-M-15), bla(CMY-2), aac(3)-IIa and aac(6’)-Ib-cr genes isolated from a patient with bloodstream infection in China. J Glob Antimicrob Resist. 2019;19:354–355. doi:10.1016/j.jgar.2019.10.027
   Web of Science ®Google Scholar
• Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M beta-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother. 2017;72(8):2145–2155. doi:10.1093/jac/dkx146
   PubMed Web of Science ®Google Scholar
• Moon DC, Seol SY, Gurung M, et al. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates. Int J Antimicrob Agents. 2010;35(1):76–79. doi:10.1016/j.ijantimicag.2009.08.003
   Web of Science ®Google Scholar
• Sandegren L, Lindqvist A, Kahlmeter G, Andersson DI. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J Antimicrob Chemother. 2008;62(3):495–503. doi:10.1093/jac/dkn222
   PubMed Web of Science ®Google Scholar
• Sorlozano-Puerto A, Lopez-Machado I, Albertuz-Crespo M, Martinez-Gonzalez LJ, Gutierrez-Fernandez J. Characterization of fosfomycin and nitrofurantoin resistance mechanisms in Escherichia coli isolated in clinical urine samples. Antibiotics. 2020;9(9). doi:10.3390/antibiotics9090534
   Web of Science ®Google Scholar
• Perera IC, Grove A. Molecular mechanisms of ligand-mediated attenuation of DNA binding by MarR family transcriptional regulators. J Mol Cell Biol. 2010;2(5):243–254. doi:10.1093/jmcb/mjq021
   PubMed Web of Science ®Google Scholar
• Yu L, Li W, Xue M, et al. Regulatory role of the two-component system bassr in the expression of the EmrD multidrug efflux in Escherichia coli. Microb Drug Resist. 2020;26(10):1163–1173. doi:10.1089/mdr.2019.0412
   Web of Science ®Google Scholar
• Naroditskaya V, Schlosser MJ, Fang NY, Lewis K. An E. coli gene emrD is involved in adaptation to low energy shock. Biochem Biophys Res Commun. 1993;196(2):803–809. doi:10.1006/bbrc.1993.2320
   Web of Science ®Google Scholar
• Phan MD, Nhu NTK, Achard MES, et al. Modifications in the pmrB gene are the primary mechanism for the development of chromosomally encoded resistance to polymyxins in uropathogenic Escherichia coli. J Antimicrob Chemother. 2017;72(10):2729–2736. doi:10.1093/jac/dkx204
   Web of Science ®Google Scholar
• Janssen AB, van Schaik W. Harder, better, faster, stronger: colistin resistance mechanisms in Escherichia coli. PLoS Genet. 2021;17(1):4. doi:10.1371/journal.pgen.1009262
   Web of Science ®Google Scholar
• Luo QX, Yu W, Zhou K, et al. Molecular epidemiology and colistin resistant mechanism of mcr-positive and mcr-negative clinical isolated Escherichia coli. Front Microbiol. 2017;8:13. doi:10.3389/fmicb.2017.02262
   Web of Science ®Google Scholar
• Osei Sekyere J, Amoako DG. Carbonyl Cyanide m-Chlorophenylhydrazine (CCCP) reverses resistance to colistin, but not to carbapenems and tigecycline in multidrug-resistant Enterobacteriaceae. Front Microbiol. 2017;8:228. doi:10.3389/fmicb.2017.00228
   PubMed Web of Science ®Google Scholar
• Trimble MJ, Mlynarcik P, Kolar M, Hancock REW. Polymyxin: alternative mechanisms of action and resistance. Cold Spring Harb Perspect Med. 2016;6(10):22. doi:10.1101/cshperspect.a025288
   Web of Science ®Google Scholar
• Ni W, Li Y, Guan J, et al. Effects of efflux pump inhibitors on colistin resistance in multidrug-resistant gram-negative bacteria. Antimicrob Agents Chemother. 2016;60(5):3215–3218. doi:10.1128/aac.00248-16
   PubMed Web of Science ®Google Scholar